×

Type to Explore

Oncology Market Analysis: Comprehensive Study & Latest Trends
Home / Report Store / Health Sciences and Bio Innovation / Oncology Market Research Report 2024

Oncology Market Research Report 2024

Oncology Market Global Industry Analysis And Forecast (2024-2032) By Diagnostics & Treatment ( Diagnostics {Biopsy, Imaging, Immunohistochemistry, Tumour Biomarkers Test, In Situ Hybridization, And Liquid Biopsy}, Treatment {Targeted Therapy, Chemotherapy, Hormonal Therapy, Immunotherapy}), Drugs Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, Immunomodulatory Drugs), Dosage Form (Solid, Liquid, Injectable), Indication (Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, And Others{Head & Neck Cancer, Prostate Cancer, Thyroid Cancer}), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End-user (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centres, Academia, Specialty Clinics) And Region

Published date: Mar 2025 Report ID: 234 Number of Pages: 250
Format:

Oncology Market Synopsis

Oncology Market Size Was Valued at USD 221.36 Billion in 2023 and is Projected to Reach USD 474.06 Billion by 2032, Growing at a CAGR of 8.83% From 2024-2032.

Oncology is the branch of medicine that deals with the prevention, diagnosis, and treatment of cancer which involves the study of tumours, cancer cells, and their growth, as well as the development of effective treatments for cancer patients.Oncology plays a crucial role in the early detection and accurate diagnosis of cancer involving various screening methods, imaging techniques, and tests to identify the presence and stage of cancer in patients.

Oncologists consider factors like cancer type, stage, patient's health condition, and individual needs to determine the most effective treatment options, including surgery, radiation therapy, chemotherapy, immunotherapy, or targeted therapies.Oncology is pushing for in-depth research to uncover the reasons and processes behind the development of cancer. This study contributes to the advancement of novel treatment options, ground-breaking medications, and enhanced therapies, resulting in improved results for individuals with cancer.Oncology has a significant impact on public health initiatives related to cancer prevention and control which includes promoting awareness about risk factors, encouraging cancer screenings, advocating for vaccination programs, and implementing tobacco control measures to reduce cancer incidence.

Top Active Players Involved Are:

“Roche Holding AG (Switzerland), Bristol Myers Squibb (United States), Kura Oncology, Inc. (United States), Johnson & Johnson (United States), Pfizer Inc. (United States), AstraZeneca (United Kingdom), Merck & Co., Inc. (United States), Novartis AG (Switzerland), AbbVie Inc. (United States), Abbott Laboratories (United States), Amgen Inc. (United States), Sanofi SA (France), Bristol-Myers Squibb Company (United States), Gilead Sciences Inc (United States), Vertex Pharmaceuticals Inc. (United States), Regeneron Pharmaceuticals Inc. (United States), GSK plc. (United Kingdom), Daiichi Sankyo Company Ltd. (Japan), Takeda Pharmaceutical Company Ltd. (Japan), Moderna Inc. (United States), Biogen Inc. (United States), BioNTech SE (Germany), Astellas Pharma Inc. (Japan), Illumina Inc. (United States), Beigene Ltd. (China), and Other Active Players.”

Oncology Market Segment Analysis:

The Oncology Market is Segmented on the basis of Diagnostics & Treatment, Treatment, Drugs Class, Dosage Form, Indication, Distribution Channel, And End-user.

By Diagnostics & Treatment, the Treatment Segment Is Expected to Dominate the Market During the Forecast Period

There are two segments by diagnostics & treatment such as diagnostics which contain sub-segments biopsy, imaging, immunohistochemistry, tumour biomarkers test, in situ hybridization, and liquid biopsy and treatment which contains sub-segments targeted therapy, chemotherapy, hormonal therapy, and immunotherapy. Among these, the treatment segment is expected to dominate the market during the forecast period.

  • The worldwide occurrence of cancer has been consistently increasing, resulting in a greater need for successful treatment choices. With the rising number of cancer cases, the need for different treatment methods is also on the rise.
  • There have been significant advancements in the research and development of cancer treatments which include the development of targeted therapies, immunotherapies, and other novel treatment approaches that have shown promising results in combating cancer. These have contributed to the dominance of the treatment segment.
  • As patients become more informed about different treatment choices, they are increasingly inclined to seek cancer treatment. Furthermore, specialized oncology services have also seen enhancements in availability and accessibility, leading to increased demand for treatment choices.
  • Healthcare infrastructure, including hospitals, clinics, and cancer centers, continues to expand and improve worldwide allowing for better diagnosis, treatment, and management of cancer.

By Application, Lung Cancer Segment Held the Largest Share In 2023

There are six segments by application such as lung cancer, colorectal cancer, breast cancer, liver cancer, bladder cancer, and others (head & neck cancer, prostate cancer, thyroid cancer). Among these, the lung cancer segment held the largest share in 2023.

  • Lung cancer is a prevalent form of cancer worldwide and is linked to high death rates. The high occurrence of lung cancer has aided in its prominence in the field of oncology. Most lung cancer cases are associated with the use of tobacco products.
  • Major progress has been made in the field of lung cancer diagnosis, including improvements in imaging methods, molecular testing, and biopsy techniques. These advancements have enhanced the ability to detect lung cancer early and accurately diagnose it, resulting in a higher need for lung cancer testing.
  • Focused treatments, especially those aimed at specific genetic changes such as EGFR and ALK, have displayed significant potential in lung cancer therapy. These treatments provide efficient options for treating specific groups of patients, resulting in improved results.
  • Globally, there has been an increase in traction for awareness campaigns and screening programs that focus on early detection and prevention of lung cancer. These efforts have resulted in higher recognition among high-risk individuals, resulting in the detection of a greater number of lung cancer cases.

Oncology Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast Period

  • North America has a developed healthcare system, which includes hospitals, specialized cancer centres, research institutions, and medical universities. The strong healthcare system in the area allows for effective identification, care, and control of a range of illnesses, such as cancer.
  • North America spends a significant amount on healthcare, showing a strong focus on healthcare services and advancements. This investment in finances supports the growth and acceptance of new technologies, state-of-the-art therapies, and advanced treatment choices.
  • The region is recognized for its significant contributions in oncology research, clinical trials, and drug development which give North America an upper hand in the market.
  • The region has been an early adopter of technological advancements in the healthcare sector due to this North America has witnessed remarkable progress in precision medicine, genomic profiling, molecular diagnostics, imaging technologies, and targeted therapies.

Oncology Market Active Players

  • Roche Holding AG (Switzerland)
  • Bristol Myers Squibb (United States)
  • Kura Oncology, Inc. (United States)
  • Johnson & Johnson (United States)
  • Pfizer Inc. (United States)
  • AstraZeneca (United Kingdom)
  • Merck & Co., Inc. (United States)
  • Novartis AG (Switzerland)
  • AbbVie Inc. (United States)
  • Abbott Laboratories (United States)
  • Amgen Inc. (United States)
  • Sanofi SA (France)
  • Bristol-Myers Squibb Company (United States)
  • Gilead Sciences Inc (United States)
  • Vertex Pharmaceuticals Inc. (United States)
  • Regeneron Pharmaceuticals Inc. (United States)
  • GSK plc. (United Kingdom)
  • Daiichi Sankyo Company Ltd. (Japan)
  • Takeda Pharmaceutical Company Ltd. (Japan)
  • Moderna Inc (United States)
  • Biogen Inc. (United States)
  • BioNTech SE (Germany)
  • Astellas Pharma Inc. (Japan)
  • Illumina Inc. (United States)
  • Beigene Ltd. (China) and Other Active Players.

Key Industry Developments in the Oncology Market:

  • In March 2024, Roche Pharma India launched Vabysmo, a medication for neovascular age-related macular degeneration and diabetic macular edema in India. The drug is cost-effective and collaborates with government and insurance companies for patient access. Vabysmo achieves global sales and offers durable treatment for retinal vision loss.
  • In January 2024, BDR Pharmaceuticals has, in a global first, introduced the prostate cancer drug enzalutamide in oral solution form. The formulation provides an effective dosage form, with lesser side effects in comparison to existing oral dosage forms of enzalutamide.

Oncology Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 221.36 Bn.

Forecast Period 2024-32 CAGR:

8.83 %

Market Size in 2032:

USD 474.06 Bn.

Segments Covered:

By Diagnostics & Treatment

  • Diagnostics
  • Biopsy
  • Imaging
  • Immunohistochemistry
  • Tumour Biomarkers Test
  • In Situ Hybridization
  • Liquid Biopsy
  • Treatment
  • Targeted Therapy
  • Chemotherapy
  • Hormonal Therapy
  • Immunotherapy

By Drugs Class

  • Cytotoxic Drugs
  • Targeted Drugs
  • Hormonal Drugs
  • Immunomodulatory Drugs

By Dosage Form

  • Solid
  • Liquid
  • Injectable

By Indication

  • Lungs Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Liver Cancer
  • Bladder Cancer
  • Others (Head & Neck Cancer, Prostate Cancer, Thyroid Cancer)

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By End-user

  • Hospitals
  • Diagnostic Laboratories
  • Diagnostic Imaging Centres
  • Academia
  • Specialty Clinics

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Increased Consumption of Alcohol and Tobacco

Key Market Restraints:

  • High Risk of Side Effects Associated with Cancer Treatments

Key Opportunities:

  • Increasing Technological Advancements

Companies Covered in the report:

  • Roche Holding AG (Switzerland), Bristol Myers Squibb (United States), Kura Oncology, Inc. (United States), Johnson & Johnson (United States), Pfizer Inc. (United States), and Other Active Players.

Chapter 1: Introduction

 1.1 Scope and Coverage



Chapter 2:Executive Summary



Chapter 3: Market Landscape

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Challenges

 3.2 Market Trend Analysis

 3.3 PESTLE Analysis

 3.4 Porter's Five Forces Analysis

 3.5 Industry Value Chain Analysis

 3.6 Ecosystem

 3.7 Regulatory Landscape

 3.8 Price Trend Analysis

 3.9 Patent Analysis

 3.10 Technology Evolution

 3.11 Investment Pockets

 3.12 Import-Export Analysis



Chapter 4: Oncology Market by By Diagnostics & Treatment

 4.1 Oncology Market Snapshot and Growth Engine

 4.2 Oncology Market Overview

 4.3 Diagnostics

  4.3.1 Introduction and Market Overview

  4.3.2 Historic and Forecasted Market Size in Value USD and

Frequently Asked Questions

What would be the forecast period in the Oncology Market research report?

The forecast period in the Oncology Market research report is 2024-2032.

Who are the key players in the Oncology Market?

Roche Holding AG (Switzerland), Bristol Myers Squibb (United States), Kura Oncology, Inc. (United States), Johnson & Johnson (United States), Pfizer Inc. (United States), AstraZeneca (United Kingdom), Merck & Co., Inc. (United States), Novartis AG (Switzerland), AbbVie Inc. (United States), Abbott Laboratories (United States), Amgen Inc. (United States), Sanofi SA (France), Bristol-Myers Squibb Company (United States), Gilead Sciences Inc (United States), Vertex Pharmaceuticals Inc. (United States), Regeneron Pharmaceuticals Inc. (United States), GSK plc. (United Kingdom), Daiichi Sankyo Company Ltd. (Japan), Takeda Pharmaceutical Company Ltd. (Japan), Moderna Inc (United States), Biogen Inc. (United States), BioNTech SE (Germany), Astellas Pharma Inc. (Japan), Illumina Inc. (United States), Beigene Ltd. (China), and Other Active Players.

What are the segments of the Oncology Market?

The Oncology Market is segmented into Diagnostics & Treatment, Treatment, Drugs Class, Dosage Form, Indication, Distribution Channel, End-user, and Region. By Diagnostics & Treatment, the market is categorized into Diagnostics (Biopsy, Imaging, Immunohistochemistry, Tumor Biomarkers Test, In Situ Hybridization, And Liquid Biopsy), Treatment, (Targeted Therapy, Chemotherapy, Hormonal Therapy, Immunotherapy). By Drugs Class, the market is categorized into Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, and Immunomodulatory Drugs. By Dosage Form, the market is categorized into Solid, Liquid, and Injectable. By Indication, The Market Is Categorized into Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, And Others (Head & Neck Cancer, Prostate Cancer, Thyroid Cancer). By Distribution Channel, the market is categorized Into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. By End-user, the market is categorized into Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, and Specialty Clinics. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).

What is the Oncology Market?

Oncology is the branch of medicine that deals with the prevention, diagnosis, and treatment of cancer which involves the study of tumors, cancer cells, and their growth, as well as the development of effective treatments for cancer patients.

How big is the Oncology Market?

Oncology Market Size Was Valued at USD 221.36 Billion in 2023 and is Projected to Reach USD 474.06 Billion by 2032, Growing at a CAGR of 8.83% From 2024-2032.

Purchase Benefits
  • Eligible for a free updated report
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours

Report ID: 234

Published Date: 2025-03-11

Number of Pages: 250

Speak To Analyst

Akshay Patil

chatsimple